3

PRIMARY DOCUMENT

Company: ENANTA PHARMACEUTICALS INC
Filed: March 20, 2013
Period of Report: March 20, 2013
Accession Number: 0000908662-13-000135

View Document ↗ View on SEC.gov ↗